Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Journey to Diagnosis of Light Chain Amyloidosis: A Real-World Experience from a Single Center in Latin America

Lucrecia Liliana Oses, Marcelina Carretero, Maria Lourdes Posadas, Erika Barbara Brulc, Elsa Mercedes Nucifora, Natalia Paola Schutz

Blood (2023) 142 (Supplement 1): 6752.

https://doi.org/10.1182/blood-2023-189323

Published: 2023

Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Blood (2023) 142 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2023-185240

Published: 2023

Journal Articles

Outcomes of Incorporating IV Daratumumab for the Treatment of AL Amyloidosis in Real World Patients from a Multicenter Registry in Latin America

Erika Barbara Brulc, Natalia Paola Schutz, Maria Lourdes Posadas, Elsa Mercedes Nucifora, Maria Adela Aguirre, Guillermina Remaggi, Patricio Duarte, Claudia Shanley, Maria Elvira Giannini

Blood (2023) 142 (Supplement 1): 6775.

https://doi.org/10.1182/blood-2023-188192

Published: 2023

Journal Articles

Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

Humberto Martinez-Cordero, Camila Peña, Natalia Paola Schutz, Virginia Bove, Fiorella Villano, Rocío Osorio, Mauricio Chandia, Cecilia Beltrán, Javier Schulz, Daniela Cardemil, Carolina Contreras, Carmen Gloria Vergara, Javiera Donoso, Marcela Espinoza, Gabriel La Rocca, Hernán López-Vidal, Pilar León, Macarena Roa, Christine Rojas, Pablo Soto, Sandra Aranda, Vivianne Torres, Paola Ochoa, Patricio Duarte, Guillermina Remaggi, Sebastian Yantorno, Ariel Corzo, Soledad Zabaljauregui, Claudia Shanley, Sergio Lopresti, Sergio Orlando, Veronica Verri, Luis Darío Quiroga, Juan Jose Garcia, Vanesa Fernandez, Dorotea Fantl, Jhoanna Ramirez, Alicia Molina, Pilar Papilco, Alex Mite, Ines Reyes, Brenner Sabando Vélez, Francisca M. Ramirez Aspiazu, Claudia Lucia Sossa, Virginia Abello, Henry Idrobo, Domingo Saavedra, Guillermo Quintero, Lina Gaviria, Rigoberto Gomez, Monica Osuna Pérez, Alicia Henao-Uribe, Luz del Carmen Tarín Arzaga, Omar Cantú-Martínez, David Gomez-Almaguer, Yarely Itzayana García-Navarrete, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Arguelles, Eloisa Riva, Isabella Novoa-Caicedo

Blood (2022) 140 (Supplement 1): 7189–7191.

https://doi.org/10.1182/blood-2022-158104

Published: 2022

Journal Articles

Demographic and Clinical Characteristics of Multiple Myeloma Patients in Latin America

Vania T.M. Hungria, Damila Trufelli, Jaqueline Saes, Karina Nakajima, Lays Leonel, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Rosane Bittencourt, Angelo Maiolino, Natalia Paola Schutz, Guillermo Quintero

Blood (2022) 140 (Supplement 1): 12487–12489.

https://doi.org/10.1182/blood-2022-163763

Published: 2022

Journal Articles

Results of an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma in Emerging Markets (INTEGRATE)

Kihyun Kim, Natalia Paola Schutz, Su-Peng Yeh, Estelle Verburgh, Fahad Alsharif, Wenming Chen, Tatiana Mitina, Wee-Joo Chng, Cathy Wu, Hui Wan, Zhongwen Huang, Meral Beksac

Blood (2021) 138 (Supplement 1): 3045.

https://doi.org/10.1182/blood-2021-147108

Published: 2021

Journal Articles

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-142823

Published: 2020

Journal Articles

BCL2 Expression Correlates with Refractory and Relapsed Classic Hodgkin Lymphoma. Its Blokeadge As a Promising Directed-Therapy

Angelica Gamboa-Cedeño, Cristaldo Nancy, MD, Victoria Otero, MD, Natalia Paola Schutz, MDMSc, Dorotea Fantl, MD, Maria Silvana Cugliari, Marta Zerga, MD, Rojas-Bilbao Erica, Hernán García Rivello, Federico Jauk, MD, Myriam Nuñez, PhD, Stella Maris Ranuncolo, MD PhD

Blood (2019) 134 (Supplement_1): 5282.

https://doi.org/10.1182/blood-2019-124452

Published: 2019

Journal Articles

A Real-Life Study of Autologous Stem-Cell Transplantation in Patients with Multiple Myeloma Older Than 65 Years in a Latin American Country

Cristian Maximiliano Seehaus, MD, Natalia Paola Schutz, MDMSc, Erika Barbara Brulc, MD, Leandro Burgos Pratx, MD, Gonzalo Ariel Ferini, MD, Jorge A Arbelbide, MD, Dorotea Fantl, MD, Ana Lisa Basquiera, MD PhD

Blood (2019) 134 (Supplement_1): 5711.

https://doi.org/10.1182/blood-2019-130171

Published: 2019

Journal Articles

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brener Sabando, MD, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Kenny Galvez, MD, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Raimundo Gazitua, MD, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Macarena Roa, MD, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5497.

https://doi.org/10.1182/blood-2019-127555

Published: 2019

Journal Articles

Real World Outcomes in Latin-American Patients with Multiple Myeloma Under 40 Years Old

Humberto Martínez-Cordero, MD, Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Macarena Alejandra Roa Salinas, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Juan Jose Garcia, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brenner Sabando, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5508.

https://doi.org/10.1182/blood-2019-130987

Published: 2019

Journal Articles

Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

Natalia Paola Schutz, MD MSc, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Dario Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 3301.

https://doi.org/10.1182/blood-2018-99-116243

Published: 2018

Journal Articles

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Camila Peña, MD, Gonzalo P Mendez, MD, Natalia Paola Schutz, MD, Eloisa Riva, MD, Ricardo Valjalo, MD, Hernán López-Vidal, MD, Alejandro Majlis, MD, Vivianne Lois, MD, Daniela Zamora, MD, Jose T Gonzalez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 5856.

https://doi.org/10.1182/blood-2018-99-113198

Published: 2018

Journal Articles

Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

Eloisa Riva, MD, Natalia Paola Schutz, MD, Camila Peña, MD, Fiorella Villano, MD, Guillermo J. Ruiz-Argüelles, FRCP, MACP, Juan Ramon Navarro, MD, Willem Bujan, MD, Lidiane Andino Neves, MD, Christine Rojas, MD, Hernán López-Vidal, MD, Angelina Rodriguez, MD, Virginia Bove, MD, Miguel Rodriguez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 2244.

https://doi.org/10.1182/blood-2018-99-111429

Published: 2018

Journal Articles

Refractory and Relapse Predictive Biomarkers in Hodgkin Lymphoma and Potential Directed-Therapy Targets

Angélica María Gamboa-Cedeño, Ms, Mariángeles Castillo, Victoria Otero, MD, Natalia Paola Schutz, MD, Dorotea Beatriz Fantl, MD, Federico Jauk, MD, Hernán García Rivello, Marta Zerga, MD, Silvana Cugliari, Erica Rojas-Bilbao, MD, Myriam Nuñez, PhD, Stella Ranuncolo, MD PhD

Blood (2018) 132 (Supplement 1): 2870.

https://doi.org/10.1182/blood-2018-99-115062

Published: 2018

Journal Articles

Frailty Evaluation in a Cohort of Onco-Hematology Patients

Erika Barbara Brulc, MD PhD, Dorotea Beatriz Fantl, MD, Maximiliano Smietniansky, MD, Natalia Paola Schutz, MD, Victoria Otero

Blood (2017) 130 (Supplement 1): 4675.

https://doi.org/10.1182/blood.V130.Suppl_1.4675.4675

Published: 2017

Journal Articles

Argentine Multicentric Experience of Carfilzomib Use in Relapsed / Refractory Multiple Myeloma. Report from the GAMM (Grupo Argentino de Mieloma Multiple)

Natalia Paola Schutz, MD, Patricio Duarte, MD, Claudia Shanley, MD, Agustina Cia, MD, Paola Ochoa, MD, Ariel Corzo, MD, Luis Dario Quiroga, MD, Sergio MARIO Orlando, MD, Romina Mariano, MD, Alicia Enrico, MD, Dardo Riveros, MD, Guillermina Remaggi, Dorotea Beatriz Fantl, MD

Blood (2017) 130 (Supplement 1): 5439.

https://doi.org/10.1182/blood.V130.Suppl_1.5439.5439

Published: 2017

Journal Articles

Acquired Factor XIII Deficiency in the Inpatient Setting: Clinical Suspicion, Impact and Treatment: Retrospective Case Series

Fernando Chuliber, MD, Natalia Paola Schutz, MD, Victoria Otero, MD, Luis Barrera, PhD, Diana Altuna, Dorotea Beatriz Fantl, MD, Marta Martinuzzo, PhD

Blood (2016) 128 (22): 1415.

https://doi.org/10.1182/blood.V128.22.1415.1415

Published: 2016

NARROW

The Journey to Diagnosis of Light Chain Amyloidosis: A Real-World Experience from a Single Center in Latin America

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Outcomes of Incorporating IV Daratumumab for the Treatment of AL Amyloidosis in Real World Patients from a Multicenter Registry in Latin America

Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

Demographic and Clinical Characteristics of Multiple Myeloma Patients in Latin America

Results of an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma in Emerging Markets (INTEGRATE)

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

BCL2 Expression Correlates with Refractory and Relapsed Classic Hodgkin Lymphoma. Its Blokeadge As a Promising Directed-Therapy

A Real-Life Study of Autologous Stem-Cell Transplantation in Patients with Multiple Myeloma Older Than 65 Years in a Latin American Country

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Real World Outcomes in Latin-American Patients with Multiple Myeloma Under 40 Years Old

Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

Refractory and Relapse Predictive Biomarkers in Hodgkin Lymphoma and Potential Directed-Therapy Targets

Frailty Evaluation in a Cohort of Onco-Hematology Patients

Argentine Multicentric Experience of Carfilzomib Use in Relapsed / Refractory Multiple Myeloma. Report from the GAMM (Grupo Argentino de Mieloma Multiple)

Acquired Factor XIII Deficiency in the Inpatient Setting: Clinical Suspicion, Impact and Treatment: Retrospective Case Series

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only